Gonadotropin Releasing Hormone: Structure & Function

Ans: Gonadotropin-releasing hormone stimulates the pituitary gland in the brain to produce and secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones cause testosterone to accumulate in the testicles of males. In women, the ovaries produce oestrogen and progesterone.

Second Answer

Ans: Gonadotropin-releasing hormone (GnRH) plays a vital role in the symphony of hormones regulating reproduction. Secreted by the brain's pituitary gland, GnRH acts like a conductor, stimulating the pituitary to release two key hormones: luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

Ans: The effects of getting too much GnRH are still being studied. Damage to the hypothalamus can also prevent the production of GnRH. This will also halt the production of FSH and LH on a daily basis. This can result in amenorrhea in women, sperm loss in men, and a loss of ovarian or test hormones.

Second Answer

Ans: While the exact effects of excessively high GnRH levels are still under investigation, a different scenario unfolds when GnRH production is compromised. Damage to the hypothalamus, the brain region responsible for GnRH production, can disrupt this delicate balance. This disruption can lead to a daily reduction in the production of FSH and LH, the hormones GnRH stimulates. This can result in amenorrhea in women, sperm loss in men, and a loss of ovarian or test hormones.

Ans: Gonadotropins are luteinizing and ovulatory hormones. They are known as luteinizing hormone (LH) and follicle-stimulating hormone (FSH) because they stimulate the gonads—in male testes and female ovaries. They are not life-related, but they are necessary for reproduction.

Second Answer

Ans: Gonadotropins are a group of hormones crucial for reproduction which classified into two main types namely luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Luteinizing hormone stimulates the gonads, which are the reproductive organs. Follicle-stimulating hormone stimulates the development of follicles in females

Ans: Parts of the brain send out neural inputs that control GnRH secretion. Sex steriods, in particular, control secretion in females via negative feedback. Furthermore, the hormone stimulates the release of progesterone and oestrogen in the ovaries. GnRH stimulates the testicles to produce testosterone in males.

Ans: Natural GnRH, such as gonadorelin hydrochloride (Factrel) and gonadorelin diacetate tetrahydrate, has long been recommended for use in the treatment of human diseases (Cystoreline).

• In clinical practise, synthetic analogues of gonadotropin-releasing hormone have largely replaced the natural hormone.
• Continuous infusion of the leuprorelin analogue is used in the treatment of breast cancer, endometriosis, and prostate cancer.

Second Answer

Ans: While naturally occurring GnRH (such as gonadorelin hydrochloride, known commercially as Factrel, and gonadorelin diacetate tetrahydrate, used in Cystoreline) was once used for treatment, clinical practice has shifted towards synthetic GnRH analogs.

• These synthetic analogs offer advantages in terms of stability and longer-lasting effects.
• For instance, continuous infusion of leuprorelin, a GnRH analog, is a common treatment for various conditions like breast cancer, endometriosis, and prostate cancer.

Ans: GnRH is thought to be a neurohormone, which is a hormone that is produced in a specific neural cell and released at its neural terminal. The hypothalamus preoptic area, which contains the majority of GnRH-secreting neurons, is an important area for GnRH production.

• The GnRH neurons are controlled by a variety of specific afferent neurons that use a variety of common transmitters (including norepinephrine, GABA, and glutamate).
• Dopamine, for example, tends to trigger the release of LH (via GnRH) in estrogen-progesterone-primed females; dopamine can inhibit the release of LH in female ovaries.

Second Answer

Ans: Gonadotropin-releasing hormone (GnRH) is classified as a neurohormone. This means it's produced by specialized nerve cells in the brain, specifically within the hypothalamus' preoptic area. This region houses the majority of GnRH-secreting neurons, making it critical for GnRH production.

• The activity of these GnRH neurons isn't random.

They are under the influence of various incoming signals (afferent neurons) that use different chemical messengers, including norepinephrine, GABA, and glutamate.

• For example, dopamine plays a complex role. In females primed with estrogen and progesterone, dopamine can stimulate the release of LH (via GnRH) to support ovulation. 

Ans: GnRH stimulates follicle-stimulating hormone (FSH) development and secretion, as well as luteinizing hormone (LH) production in the pituitary (LH). These processes are governed by the size and frequency of GnRH pulses, as well as feedback from androgens and estrogens.

• In terms of GnRH secretion, females and males differ. GnRH is secreted in pulses at a constant frequency in males.
• However, the duration of the pulses changes during the menstrual cycle, and a significant burst in GnRH occurs just before ovulation.

Second Answer

Ans: Gonadotropin-releasing hormone (GnRH) acts like a conductor in the brain, stimulating the pituitary gland to produce two key hormones. The size and frequency of GnRH pulses determine the downstream effects. Additionally, sex hormones like androgens and estrogens helps regulate GnRH release. Here's where the difference between males and females comes in:

• In males, GnRH is released in pulses at a consistent frequency, ensuring a steady production of FSH and LH.
• In females, GnRH release is more dynamic. Throughout the menstrual cycle, the GnRH pulse duration changes. Just before ovulation, a surge, or significant burst, in GnRH occurs, triggering the release of LH, which is critical for egg release (ovulation).

Ans: The medical applications of gonadotropin-releasing hormone are as follows:

• In clinical practice, synthetic analogues of gonadotropin-releasing hormone have largely replaced the natural hormone.
• It's been used to treat precocious puberty.
• GnRH agonists are effective in protecting the ovaries during chemotherapy in terms of menstruation regeneration or repair, premature ovarian failure, and ovulation.

Second Answer

Ans: The medical applications of gonadotropin-releasing hormone are as follows:

• These analogs can help delay puberty in children who experience it prematurely.
• During chemotherapy, GnRH analogs can help shield the ovaries, potentially promoting menstrual function recovery or repair after treatment.
• They may also play a role in managing premature ovarian failure, a condition where the ovaries stop functioning prematurely.
• In some cases, GnRH analogs can be used to regulate ovulation.

Ans: The functions of gonadotropin-releasing hormone are as follows:

• GnRH is secreted in the hypophyseal bloodstream portal at the median eminence. 
• The gonadotropin-releasing hormone receptor (GnRHR) is a seven-transmembrane G protein-coupled receptor that activates the phospholipase C beta isoform, which then mobilises calcium and protein kinase C.
• During the reproductive years, pulse activity is critical for successful reproductive function, as regulated by feedback loops. However, once a pregnancy is established, GnRH activity is no longer required.

Second Answer

Ans: The functions of gonadotropin-releasing hormone are as follows:

• At the pituitary, GnRH interacts with specific receptors (GnRHR) on the surface of pituitary cells.
• These receptors belong to a class called G protein-coupled receptors. When GnRH binds to its receptor, it triggers a cascade of events inside the cell:
• Activation of phospholipase C beta isoform: This enzyme plays a crucial role in cellular signaling.
• Mobilization of calcium and protein kinase C.
• These molecules act as messengers within the cell, ultimately leading to the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH).

Ans: As is customary for peptide representation, the sequence is given from the amino terminus to the carboxyl terminus. Because all amino acids are in their L-shape, standard presentation represents the absence of chirality classification. With the exception of pyroGlu, which refers to pyroglutamic acid, a glutamic acid derivative, the abbreviations are the standard abbreviations for the corresponding proteinogenic amino acids. The presence of NH₂ at the carboxyl terminal indicates that it begins as a carboxylate and ends as a free carboxylate.

Second Answer

Ans: Gonadotropin releasing hormone consists of 10 amino acids produced in the arcuate nuclei of the hypothalamus. Each amino acid has a standard abbreviation to simplify the sequence representation.

• These abbreviations assume all the amino acids are in their L-form (a specific spatial arrangement), which is the most common form found in proteins.
• The sequence ends with "NH2," indicating a free amino group at the carboxyl terminus.

Ans: Hypothalamic-pituitary dysfunction can disrupt pulsatile behaviour through disruption (i.e., hypothalamic suppression) or organic lesions (trauma, tumour). Prolactin levels that are high reduce GnRH activity. Hyperinsulinemia, on the other hand, increases pulse activity, which leads to disorderly LH and FSH activity, as seen in polycystic ovary syndrome (PCOS). 

Second Answer

Ans: When the hypothalamus, the brain region responsible for GnRH production, is suppressed, it can disrupt the normal pulsing behavior. Physical damage to the hypothalamus, such as from trauma or a tumor, can also disrupt GnRH pulsing. High levels of prolactin, another hormone, can dampen GnRH activity, affecting the pulsing pattern. Excess insulin in the blood (hyperinsulinemia) can have the opposite effect. This hormonal imbalance is often seen in a condition called polycystic ovary syndrome (PCOS).